tiprankstipranks
Advertisement
Advertisement

OLMA Stock Latest News

Olema Oncology price target lowered to $46 from $52 at JPMorgan
The FlyOlema Oncology price target lowered to $46 from $52 at JPMorgan
10d ago
OLMA
Olema Oncology appoints Jason O’Byrne as CFO
PremiumThe Fly
Olema Oncology appoints Jason O’Byrne as CFO
10d ago
VIR
OLMA
Olema Pharmaceuticals Names New Chief Financial Officer
PremiumCompany Announcements
Olema Pharmaceuticals Names New Chief Financial Officer
13d ago
8K
OLMA
Olema Oncology price target lowered to $20 from $23 at Goldman Sachs
PremiumThe Fly
Olema Oncology price target lowered to $20 from $23 at Goldman Sachs
15d ago
OLMA
Olema Oncology price target lowered to $59 from $62 at Citi
PremiumThe Fly
Olema Oncology price target lowered to $59 from $62 at Citi
15d ago
OLMA
Olema Oncology price target lowered to $36 from $38 at H.C. Wainwright
PremiumThe FlyOlema Oncology price target lowered to $36 from $38 at H.C. Wainwright
15d ago
OLMA
Tyler Van Buren Reiterates Buy on Olema, Citing Palazestrant’s Late-Stage Differentiation and Multiple Value-Creating Catalysts
Premium
Ratings
Tyler Van Buren Reiterates Buy on Olema, Citing Palazestrant’s Late-Stage Differentiation and Multiple Value-Creating Catalysts
16d ago
OLMA
Olema Pharmaceuticals: Buy Rating Reiterated as Palazestrant Phase 3 Catalysts Loom; $24 Price Target Maintained
Premium
Ratings
Olema Pharmaceuticals: Buy Rating Reiterated as Palazestrant Phase 3 Catalysts Loom; $24 Price Target Maintained
16d ago
OLMA
Olema Oncology reports Q2 EPS (61c), consensus (56c)
PremiumThe Fly
Olema Oncology reports Q2 EPS (61c), consensus (56c)
16d ago
OLMA
OLMA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OLMA Earnings this Week: How Will it Perform?
17d ago
OLMA
Waste Connections, Entergy, Bj’s, Olema, Tenet Insider Shock
PremiumWeekend Updates
Waste Connections, Entergy, Bj’s, Olema, Tenet Insider Shock
25d ago
BJ
ETR
Olema Maintained at Buy as Differentiated Pipeline and Robust Trial Strategy Support Unchanged $24 Price Target
PremiumRatings
Olema Maintained at Buy as Differentiated Pipeline and Robust Trial Strategy Support Unchanged $24 Price Target
2M ago
OLMA
Olema Investors Back Board, Pay and Auditor Decisions
PremiumCompany AnnouncementsOlema Investors Back Board, Pay and Auditor Decisions
2M ago
8K
OLMA
Olema Pharmaceuticals: Clinical Momentum and Strategic Flexibility Support Buy Rating and Maintain $38 Price Target
Premium
Ratings
Olema Pharmaceuticals: Clinical Momentum and Strategic Flexibility Support Buy Rating and Maintain $38 Price Target
3M ago
OLMA
Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target
Premium
Ratings
Olema Pharmaceuticals: Buy Rating Reiterated as Pipeline Progress Supports Attractive Risk/Reward with Unchanged $62 Price Target
3M ago
OLMA
Olema Oncology announces collaboration, supply agreement with Bayer
PremiumThe Fly
Olema Oncology announces collaboration, supply agreement with Bayer
3M ago
OLMA
Olema, Bayer launch OP-3136 prostate cancer collaboration
PremiumCompany Announcements
Olema, Bayer launch OP-3136 prostate cancer collaboration
3M ago
8K
OLMA
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
PremiumCompany Announcements
Olema Highlights Encouraging OP-3136 Phase 1 Oncology Results
3M ago
8K
OLMA
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
PremiumThe Fly
Citi opens ‘upside 90-day catalyst watch’ on Olema Oncology
3M ago
OLMA
Olema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
PremiumRatingsOlema Pharmaceuticals: Citi’s Anupam Rama Reiterates Buy on Underappreciated Palazestrant Upside and Long-Term Pipeline Catalysts
4M ago
OLMA
Olema Oncology price target lowered to $35 from $38 at Guggenheim
Premium
The Fly
Olema Oncology price target lowered to $35 from $38 at Guggenheim
4M ago
PFE
OLMA
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Differentiated KAT6i and Palazestrant Pipeline Catalysts Underpin Buy Rating
4M ago
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >